About Ozanimod,Ozanimod
            
            Class: | Sphingosine 1-phosphate receptor modulator  
Use: | Treatment of relapsing forms of multiple sclerosis (MS)  
Adult dose: | Initial dose: 0.23 mg orally once daily for 7 days, then increase to 0.46 mg orally once daily  
Pediatric dose: | Safety and efficacy not established in pediatric patients  
Side effects: | Headache, elevated liver enzymes, infections, diarrhea, nausea, fatigue  
Contraindications: | Hypersensitivity to ozanimod or any component of the formulation; active infectio
         
        
            
                
                
                    
                        Drug Class
                    
                    Sphingosine 1-phosphate receptor modulator
                 
                
                
                    
                        Uses & Indications
                    
                    Treatment of relapsing forms of multiple sclerosis (MS)
                 
                
                
                    
                        Storage Requirements
                    
                    Store at room temperature (20°C to 25°C or 68°F to 77°F); protect from moisture
                 
                
                
                    
                        Manufacturer & Packaging
                    
                    
                        Manufacturer: Bristol Myers Squibb Pharma EEIG, Ireland
                    
                    
                    Package Size
                    7 capsules (4 caps x 0.23 mg + 3 caps x 0.46 mg)
                    
                    
                    Price & Supplier
                    
                        Price in UAE: AED 2009.00
                    
                    
                 
             
            
                
                
                    
                        Dosage Information
                    
                    
                        Adult Dose
                    
                    
                        Initial dose: 0.23 mg orally once daily for 7 days, then increase to 0.46 mg orally once daily
                    
                    
                        Pediatric Dose
                    
                    
                        Safety and efficacy not established in pediatric patients
                    
                 
                
                
                    
                        Side Effects
                    
                    Headache, elevated liver enzymes, infections, diarrhea, nausea, fatigue
                 
             
         
        
        
            
                Contraindications & Precautions
            
            Hypersensitivity to ozanimod or any component of the formulation; active infection; severe liver impairment
         
        
        
            
                Important Warnings
            
            Risk of serious infections, liver injury, bradycardia, and fetal harm; monitor liver function and heart rate; not recommended for use in pregnancy unless necessary
         
        
        
        
        
        
        
        
        
            
                Medical Disclaimer
            
            
                This information is for educational purposes only and should not replace professional medical advice. 
                Always consult with a licensed healthcare provider or pharmacist in the UAE before taking any medication. 
                The information presented here is specific to medicines available in UAE pharmacies and is regularly updated 
                to ensure accuracy for patients and healthcare professionals in the United Arab Emirates.